🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

📢Job alert! Postdoctoral Research Associate in Behavioural Science working on the PROTECT-C study (protect-c.co.uk) with Jo Waller and the WPP team! 3 year post with qualitative interviews with almost 100 participants! Link below to apply: qmul-jobs.tal.net/vx/mobile-0/ap…

First Call for abstracts #BGCS2025 Looking forward to an exciting meeting next year! BGCS BGCS fellows ESGO European Network of Young Gynae Oncologists IGCS Ovarian Cancer Action The Eve Appeal Ovacome - the ovarian cancer support charity GO Girls Peaches Womb Cancer Trust Target Ovarian Cancer Wolfson Institute of Population Health Cancer Screening, Prevention and Early Diagnosis Cancer Screening, Prevention & Early Diagnosis

Congratulations to the amazing Xia Wei for passing her PhD viva today!! A huge thank you to her examiners James Buchanan and Dr Gurdeep Sagoo Wolfson Institute of Population Health Cancer Screening, Prevention and Early Diagnosis Barts Cancer Institute (Queen Mary) Women's Precision Prevention

eur01.safelinks.protection.outlook.com/?url=https%3A%…. Looking forward to working with NHS Digitrials on our PROTECTC study study study Thx to our funder Yorkshire Cancer Research , stakeholders and supporters Good to see Wolfson Institute of Population Health Cancer Screening, Prevention and Early Diagnosis associated with 2 of the 3 cancer studies. Peter Sasieni 👍

nature.com/articles/s4146… Great to see our paper out in Nature Communications 2024 showing Immunotherapy can improve response to chemotherapy in high-grade serous ovarian cancer. Congratulations Frances Balkwill Dr Samar Elorbany. Barts Cancer Institute (Queen Mary) Wolfson Institute of Population Health Cancer Screening, Prevention and Early Diagnosis Women's Precision Prevention

‼️ Calling people interested in a patient and public involvement (PPI) workshop for PROTECT-C! 🗺️ Where: Charterhouse Square, Barbican, London, UK ⏲️ When: 10th of January from 10am-4pm ❓ How: Complete this form - forms.office.com/r/01FetvtrZP Prof Ranjit Manchanda Wolfson Institute of Population Health Queen Mary University of London

Thank you to the amazing members of the public who attended our workshop for PROTECT-C on Friday! 🙏 We are so grateful for the input, comments, and suggestions to improve the PROTECT-C study! More about PROTECT-C: protect-c.co.uk Prof Ranjit Manchanda Wolfson Institute of Population Health Cancer Screening, Prevention and Early Diagnosis

Our postdoc Caitlin Fierheller, PhD was accepted to participate in the Springboard Women’s Development Programme 2025! There were a high number of applications and a strong candidate field. Congratulations Caitlin! Prof Ranjit Manchanda Cancer Screening, Prevention and Early Diagnosis Wolfson Institute of Population Health Barts and The London, Queen Mary

The WPP team at #ESGO2025 in Rome! Prof Ranjit Manchanda

Congratulations to Sam Oxley on presenting his work from the PRESCORES study at #ESGO2025 - Health-related quality of life after risk-reducing hysterectomy in women with Lynch syndrome These utility scores will be useful in informing clinical practice. Prof Ranjit Manchanda

The WPP team at #ESGO2025 presenting our work in precision prevention of women’s cancers today 😊 Prof Ranjit Manchanda

Delighted to be appointed Commissioner on the lancet commission of Ovarian Cancer and co-chair the screening prevention and early diagnosis (SPED) working group. Excellent launch meeting in Nice. Thx to chairs Isabelle Ray-Coquard and Kathleen Moore.

doi.org/10.1016/j.ajog… Delighted to see our paper on sys rev & meta-analysis of Uptake & patient-related outcomes of mainstreaming genetic testing in AJOG. Mainstreaming gene testing is assoc with high uptake & satisfaction, low - decision conflict, regret, post-test distress

qmul-jobs.tal.net/vx/appcentre-e… We have advertised for a Clinical Nurse Specialist in Gynae Oncology to join our Women's Precision Prevention Team at QMUL, and Dept of Gynae Oncology at Barts Health. A key part will be supporting implementation of a new ovarian cancer surveillance